Three Signals, One Story — How Cnvrg Connects Your Mouth, Blood, and Sleep

Angelica is 37. She sleeps seven hours most nights, exercises twice a week, and eats reasonably well. Her last physical came back normal — cholesterol fine, blood pressure fine, doctor satisfied. She doesn't feel sick. She just feels like things have gotten slightly harder: workouts take longer to recover from, mornings are foggier, energy dips earlier in the afternoon. Nothing dramatic enough to bring up at a doctor's appointment. Just the ambient sense that something has shifted.

This is the exact scenario that a single-panel health test misses — and what connecting three data streams together can start to reveal.

Signal one — the oral panel

Angelica's oral microbiome sample comes back with low relative abundance of bacteria in the Neisseria genus — the nitrate-reducing species on her tongue that convert dietary nitrate to nitrite, which her body then uses to produce nitric oxide. Vanhatalo et al. demonstrated in a controlled crossover trial that people with higher Neisseria and Rothia abundance showed greater increases in plasma nitrite in response to dietary nitrate — directly demonstrating that the bacterial community controls how much nitric oxide the body actually produces from food. The bacteria are the enzymatic step. Low Neisseria, on its own: interesting but not conclusive.

Signal two — the blood panel

Angelica's blood results show elevated high-sensitivity C-reactive protein at 2.8 mg/L — technically in the intermediate risk range but solidly above the low-risk threshold of 1.0 mg/L. The connection between the oral microbiome and CRP runs through multiple pathways. Nitric oxide, produced partly through Angelica's now-depleted Neisseria community, is a natural suppressor of the molecular switch that drives inflammatory cytokine production and, downstream, CRP synthesis in the liver. When nitric oxide availability falls, the anti-inflammatory brake on this system weakens. Bacterial DNA from oral-origin species has been found in the atherosclerotic plaques of all 42 cardiovascular patients in one study — the immune response to these circulating bacteria drives CRP elevation, often persistently. Elevated CRP and low Neisseria, same person: the pattern is beginning to cohere.

Signal three — the wearable

Angelica's RMSSD — a measure of heart rate variability — has been declining over the past three months. Not dramatically, but consistently. She hasn't changed her training. High variability means the parasympathetic system is engaged and healthy. Low variability means sympathetic dominance, which is associated with stress, poor recovery, and elevated systemic inflammation. Whelton et al. analyzed 6,735 participants in the Multi-Ethnic Study of Atherosclerosis and found that people in the highest resting heart rate quintile were 34 percent more likely to have hs-CRP above 3 mg/L compared to those with the lowest resting heart rate — after controlling for BMI, blood pressure, lipids, and metabolic syndrome.

One story, not three findings

What's happening with Angelica isn't three separate problems. It's one process, visible from three angles. Low Neisseria reduces her nitric oxide output. That reduces the anti-inflammatory signal in her vasculature and immune system. Her CRP rises — measured in blood. Her autonomic nervous system, chronically bathing in higher-than-normal inflammatory cytokine levels, shifts toward sympathetic dominance. Her HRV falls — measured on her wrist, every night, while she sleeps.

None of those three data points alone would have triggered concern. Her CRP of 2.8 mg/L is elevated but not alarming. Her HRV decline is subtle. Her Neisseria count is low but still in a range where most clinicians wouldn't act. It's the directional convergence — all three trending the same way, all mechanistically connected — that tells a different story than any single panel can.

Standard annual bloodwork doesn't include oral microbiome sequencing. Oral microbiome panels don't come with HRV data. Wearables generate data in isolation from any inflammatory context. The traditional model of health monitoring measures each system separately, at a single point in time, and looks for values outside a population-derived reference range. That model is well-designed for catching disease. It's poorly designed for catching the kind of slow, interconnected drift that precedes disease.

Angelica's story isn't a diagnosis. It's a hypothesis, generated from three converging signals, that something is worth paying attention to. That's a different kind of health intelligence than a normal blood test provides.

Sources

Vanhatalo A et al. Free Radic Biol Med. 2018. PMC6191927. Mougeot JL et al. J Oral Microbiol. 2017. PMID: 28326156. Whelton SP et al. Am J Cardiol. 2014. PMID: 24393259. Tegegne BS et al. Commun Biol. 2023. DOI: 10.1038/s42003-023-05376-y.